465 (Rizatriptan benzoate 5 mg (base))
Pill imprint 465 has been identified as Rizatriptan benzoate 5 mg (base).
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
Rizatriptan benzoate
- Imprint:
- 465
- Strength:
- 5 mg (base)
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- 68462-0465
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
corn starch
ferric oxide red
magnesium stearate
silicon dioxide
More about rizatriptan
Consumer resources
- Other brands: Maxalt, Maxalt-MLT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
